Real-time enrollment status for this neuroblastoma clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 11:38 AM UTC
| NCT Number | NCT06172296 |
| Recruiting Status | Recruiting |
| Condition | Neuroblastoma |
| Phase | PHASE3 |
| Target Enrollment | 478 participants |
| Active Locations | 157 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 25, 2026 (1 week ago) |
As of September 2, 2026: Clinical trial NCT06172296 is currently recruiting participants. This phase3 study for neuroblastoma is actively seeking new participants at 157 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06172296 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 157 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06172296 was last updated 1 week ago (August 25, 2026). HelloStudys verifies this status automatically.